{"abstract": "Pfizer agreed to buy the maker of pain medication for $3.6 billion in cash, in the giant drug maker\u2019s first major deal since its blockbuster purchase of Wyeth last year.", "web_url": "https://dealbook.nytimes.com/2010/10/12/pfizer-to-buy-king-pharmaceuticals-for-3-6-billion/", "snippet": "Pfizer agreed to buy the maker of pain medication for $3.6 billion in cash, in the giant drug maker\u2019s first major deal since its blockbuster purchase of Wyeth last year.", "lead_paragraph": "2:25 p.m. | Updated Pfizer stepped up the consolidation in the drug industry on Tuesday with a $3.6 billion deal to buy King Pharmaceuticals, a maker of pain medications.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer to Buy King Pharmaceuticals for $3.6 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "KING PHARMACEUTICALS INC", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}], "pub_date": "2010-10-12T12:24:04+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/87762a3a-f8cc-54f8-bd7b-dd8845819eba", "word_count": 558, "uri": "nyt://article/87762a3a-f8cc-54f8-bd7b-dd8845819eba"}